Inventor · disambiguated record
David Azorsa
Also filed as: AZORSA DAVID · AZORSA DAVID O
6 granted patents·5 pending applications·36 citations·filing 2005–2022
75Inventor score
Files withSYSTEMS ONCOLOGY LLC4TRANSLATIONAL GENOMICS RES INST4THE TRANSLATIONAL GENOMICS RES INST2TGEN1
Top patents by PatentIndex Score
11 records- 0189US7402389B2Compositions and methods for prognosis of cancersTRANSLATIONAL GENOMICS RES INST·Filed 2005·Granted Jul 22, 2008·29 cites·4 claims
- 0284US9738717B2Hybridoma clones, monoclonal antibodies, and methods of useTHE TRANSLATIONAL GENOMICS RES INST·Filed 2013·Granted Aug 22, 2017·7 cites·15 claims
- 0370US2024229033A1Compositions for Inhibiting Growth of Targeted CellsSYSTEMS ONCOLOGY LLC·Filed 2022·Application pending·0 cites
- 0470US2024229032A1Multitargeting RNA Immunotherapy CompositionsSYSTEMS ONCOLOGY LLC·Filed 2022·Application pending·0 cites
- 0570US2024240178A1Sirna constructs for inhibiting gene expression in targeted cancer cellsSYSTEMS ONCOLOGY LLC·Filed 2022·Application pending·0 cites
- 0670US2024240177A1Multitargeting rna compositionsSYSTEMS ONCOLOGY LLC·Filed 2022·Application pending·0 cites
- 0759US2010120025A1Compositions and Methods for Prognosis, Diagnosis, Prevention and Treatment of CancersTGEN·Filed 2008·Application pending·0 cites
- 0854US9850303B2Hybridoma clones and monoclonal antibodies to tetraspanin 8TRANSLATIONAL GENOMICS RES INST·Filed 2014·Granted Dec 26, 2017·0 cites·19 claims
- 0953US9862773B2Hybridoma clones and monoclonal antibodies to CD9TRANSLATIONAL GENOMICS RES INST·Filed 2014·Granted Jan 9, 2018·0 cites·19 claims
- 1053US9611319B2Hybridoma clones and monoclonal antibodies to fibroblast growth factor 4THE TRANSLATIONAL GENOMICS RES INST·Filed 2014·Granted Apr 4, 2017·0 cites·7 claims
- 1138US9193785B2Hybridoma clones and monoclonal antibodies to ING4TRANSLATIONAL GENOMICS RES INST·Filed 2013·Granted Nov 24, 2015·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when David Azorsa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →